Guidance

Pneumococcal vaccination: guidance for health professionals

Information for healthcare practitioners on the changes to the infant pneumococcal vaccination schedule.

Documents

Pneumococcal vaccination: guidance for HCWs on the changes to the infant schedule

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.

Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.

The PCV13 immunisation schedule has therefore been changed as follows:

  • infants born on or after 1 January 2020 should be offered a single dose of PCV13 alongside their routine DTaP/IPV/Hib/HepB and rotavirus immunisations at 12 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 1+1 PCV13 schedule

  • infants born on or before 31 December 2019 will continue to receive two doses of PCV13 vaccine alongside their routine immunisations at 8 and 16 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 2+1 PCV13 schedule

Published 13 December 2019